NCT01297192View on ClinicalTrials.gov

A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Healthy VolunteersPharmacokinetics of Mirabegron
Interventions
DRUG

solifenacin succinate

Oral

DRUG

mirabegron

Oral

Trial Locations (1)

75015

Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY